BrainStorm Cell Therapeutics
BCLI
#10403
Rank
NZ$11.43 M
Marketcap
NZ$1.04
Share price
0.00%
Change (1 day)
-61.56%
Change (1 year)

Market capitalization of BrainStorm Cell Therapeutics (BCLI)

Market cap: NZ$11.43 Million

As of December 2025 BrainStorm Cell Therapeutics has a market cap of NZ$11.43 Million. This makes BrainStorm Cell Therapeutics the world's 10403th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of BrainStorm Cell Therapeutics from 2008 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$11.43 M-53.83%
2024NZ$24.77 M17.18%
2023NZ$21.14 M-77.6%
2022NZ$94.39 M-55.57%
2021NZ$0.21 B-3.65%
2020NZ$0.22 B49.72%
2019NZ$0.14 B34.06%
2018NZ$0.10 B5.63%
2017NZ$0.10 B51.77%
2016NZ$68.52 M-12.04%
2015NZ$77.9 M-16.08%
2014NZ$92.83 M140.46%
2013NZ$38.6 M-5.1%
2012NZ$40.68 M23.2%
2011NZ$33.02 M39.92%
2010NZ$23.6 M-13.6%
2009NZ$27.31 M378.27%
2008NZ$5.71 M

End of Day market cap according to different sources

On Dec 9th, 2025 the market cap of BrainStorm Cell Therapeutics was reported to be:

NZ$8.22 Million
by Nasdaq info icon info icon
NZ$11.43 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Gilead Sciences
GILD
NZ$257.88 B 2,254,331.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
NZ$12.71 B 111,081.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
NZ$74.55 B 651,699.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$44.38 B 387,956.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
NZ$0.23 B 1,936.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
NZ$18.88 B 165,008.30%๐Ÿ‡บ๐Ÿ‡ธ USA